Monte Rosa Therapeutics logo

Monte Rosa Therapeutics share price today

(GLUE)

Monte Rosa Therapeutics share price is $7.05 & ₹600.65 as on 25 Dec 2024, 2.30 'hrs' IST

$7.05

-0.09

(-1.26%)

Market is closed - opens 8 PM, 26 Dec 2024

View live Monte Rosa Therapeutics share price in Dollar and Rupees. Guide to invest in Monte Rosa Therapeutics from India. Also see the sentimental analysis on Indian investors investing in Monte Rosa Therapeutics. Get details on the Indian mutual funds that are investing in Monte Rosa Therapeutics. Get Analyst recommendations and forecasts along with all the Monte Rosa Therapeutics's financials.

Monte Rosa Therapeutics share price movements

  • Today's Low: $6.90
    Today's High: $7.22

    Day's Volatility :4.43%

  • 52 Weeks Low: $3.21
    52 Weeks High: $12.40

    52 Weeks Volatility :74.11%

Monte Rosa Therapeutics Returns

PeriodMonte Rosa Therapeutics IncSector (Health Care)Index (Russel 2000)
3 Months
31.53%
-9.0%
0.0%
6 Months
108.58%
-4.6%
0.0%
1 Year
22.4%
3.0%
0.0%
3 Years
-65.17%
0.0%
-21.1%

Monte Rosa Therapeutics Key Statistics

in dollars & INR

Previous Close
$7.14
Open
$7.13
Today's High
$7.22
Today's Low
$6.9
Market Capitalization
$433.1M
Today's Volume
$535.5K
52 Week High
$12.4
52 Week Low
$3.21
Revenue TTM
$15.0M
EBITDA
$-121.1M
Earnings Per Share (EPS)
$-1.78
Profit Margin
0.0%
Quarterly Earnings Growth YOY
0.0%
Return On Equity TTM
-61.23%

How to invest in Monte Rosa Therapeutics from India?

It is very easy for Indian residents to invest directly in Monte Rosa Therapeutics from India. Indian investors can open a free US stocks account on the INDmoney app. You can find live prices of the Monte Rosa Therapeutics stock in both Indian Rupees (INR) and US Dollars (USD). Search for Monte Rosa Therapeutics or GLUE on the INDmoney app and click on Buy or SIP. You can invest by choosing quantities of shares of Monte Rosa Therapeutics or rupee/ dollar value or set up a fixed SIP amount to be invested every month or week.

For example: You can easily buy Rs.100 worth of Monte Rosa Therapeutics shares which would translate to 0.121 fractional shares of Monte Rosa Therapeutics as of today. Learn more about fractional investing.

Indians can now also easily transfer and add money to their US stocks account via the INDmoney app. Invest in US Stocks from India, including recognised companies like Monte Rosa Therapeutics, in just a few clicks!

Returns in Monte Rosa Therapeutics for Indian investors in Rupees

Investment Value

₹1,00,000

  • 1Y

  • 3Y

  • 5Y

  • 7Y

  • 10Y

Monte Rosa Therapeutics investment value today

Current value as on today

₹1,24,634

Returns

₹24,634

(+24.63%)

Returns from Monte Rosa Therapeutics Stock

₹22,396 (+22.4%)

Dollar Returns

₹2,239 (+2.24%)

Indian investors sentiment towards Monte Rosa Therapeutics

-93%

Period: Sep 26, 2024 to Dec 25, 2024. Change in 30 Days versus previous period

Search volume for Monte Rosa Therapeutics on INDmoney from India has reduced in the last 30 days as on Dec 26, 2024. -93% less investors are searching Monte Rosa Therapeutics in the last 30 days versus the previous period.

Global Institutional Holdings in Monte Rosa Therapeutics

  • NEA Management Company, LLC

    12.52%

  • T. Rowe Price Associates, Inc.

    10.74%

  • venBio Select Advisor LLC

    9.42%

  • FMR Inc

    8.30%

  • Baker Bros Advisors LP

    8.00%

  • Suvretta Capital Management, LLC

    4.33%

Analyst Recommendation on Monte Rosa Therapeutics

Buy

    92%Buy

    7%Hold

    0%Sell

Based on 14 Wall street analysts offering stock ratings for Monte Rosa Therapeutics(by analysts ranked 0 to 5 stars)

Based on 14 analyst
  • Current
  • 1M Ago
  • 3M Ago
Buy
13
13
12
Hold
1
1
2
Sell
0
0
0

Analyst Forecast on Monte Rosa Therapeutics

What analysts predicted

Upside of 133.03%

Current:

$7.05

Target:

$16.43

Insights on Monte Rosa Therapeutics

  • Price Movement

    In the last 7 days, GLUE stock has moved up by 8.3%
  • GLUE vs ALNY (1 yr)

    In the last 1 year, Alnylam Pharmaceuticals, Inc. has given 27.2% return, outperforming this stock by 1.8%
  • GLUE vs VRTX (3 yr)

    In the last 3 years, Vertex Pharmaceuticals Incorporated has given 25.2% return, outperforming this stock by 91.5%
  • Price to Sales

    ForGLUE every $1 of sales, investors are willing to pay $31.9, whereas for Alnylam Pharmaceuticals, Inc., the investors are paying $14.7 for every $1 of sales.

Monte Rosa Therapeutics Technicals Summary

Sell

Neutral

Buy

Monte Rosa Therapeutics is currently not in a favorable trading position ( SELL ) according to technical analysis indicators.

Monte Rosa Therapeutics Vs Peers

Company Name1 Month6 Month1 Year3 Years5 Years
Monte Rosa Therapeutics Inc
-18.02%
108.58%
22.4%
-65.17%
-63.53%
Regeneron Pharmaceuticals, Inc.
-5.12%
-32.01%
-18.29%
12.56%
91.19%
Biontech Se
-3.72%
41.99%
6.11%
-55.22%
226.93%
Alnylam Pharmaceuticals, Inc.
-3.99%
-1.52%
23.75%
50.98%
112.09%
Vertex Pharmaceuticals Incorporated
-12.61%
-13.61%
0.03%
83.58%
86.41%
Company NameP/E RatioP/B RatioPEG RatioEPSROEROADiv YieldBVPS
Monte Rosa Therapeutics Inc
1.25
NA
NA
-0.95
-0.61
-0.28
NA
3.35
Regeneron Pharmaceuticals, Inc.
17.67
17.67
1.06
45.07
0.17
0.07
NA
272.04
Biontech Se
160.8
NA
0.04
-3.11
-0.02
-0.01
NA
79.73
Alnylam Pharmaceuticals, Inc.
NA
NA
-0.49
-0.19
-15.01
-0.03
NA
0.25
Vertex Pharmaceuticals Incorporated
32.84
NA
1.06
0.51
-0.03
0.12
NA
60.65
Company NameAnalyst ViewMarket Cap5 Years Return %PE RatioProfit Margin
Monte Rosa Therapeutics Inc
Buy
$433.1M
-63.53%
1.25
0.0%
Regeneron Pharmaceuticals, Inc.
Buy
$78.5B
91.19%
17.67
33.61%
Biontech Se
Buy
$27.4B
226.93%
160.8
-15.36%
Alnylam Pharmaceuticals, Inc.
Buy
$31.4B
112.09%
NA
-15.86%
Vertex Pharmaceuticals Incorporated
Buy
$105.1B
86.41%
32.84
-4.51%

About Monte Rosa Therapeutics

small molecule protein degraders are set to reshape the way by which diseases will be treated. our rational approach in targeting disease-causing proteins for degradation will deliver pioneering therapies for cancer and beyond. headquartered in boston with additional laboratory facilities in basel, monte rosa therapeutics is a private company launched in 2020. initially seeded by versant ventures and incubated at ridgeline discovery in basel, and the institute of cancer research in london, monte rosa has raised $32.5 million from versant and new enterprise associates. academic co-founders are prof. raj chopra and prof. ian collins of the institute for cancer research, uk.
Organization
Monte Rosa Therapeutics
Employees
133
CEO
Dr. Markus Warmuth M.D.
Industry
Services

Management People of Monte Rosa Therapeutics

NameTitle
Dr. Markus Warmuth M.D.
President, CEO & Director
Dr. Filip Janku M.D., Ph.D.
Chief Medical Officer
Ms. Jennifer Champoux
Chief Operating Officer
Dr. John C. Castle Ph.D.
Chief Data & Information Officer
Dr. Sharon Townson Ph.D.
Chief Scientific Officer
Mr. Andrew Funderburk
Senior VP and Head of IR & Strategic Finance
Mr. Philip Nickson J.D., Ph.D.
Chief Business & Legal Officer
Mr. Magnus Walter DPHIL
Senior Vice President of Drug Discovery
Mr. Edmund Dunn
Vice President & Corporate Controller

Important FAQs about investing in Monte Rosa Therapeutics from India :

What is Monte Rosa Therapeutics share price today?

Monte Rosa Therapeutics share price today stands at $7.05, Open: $7.13 ; Previous Close: $7.14 ; High: $7.22 ; Low: $6.90 ; 52 Week High: $12.40 ; 52 Week Low: $3.21. The stock opens at $7.13, after a previous close of $7.14. The stock reached a daily high of $7.22 and a low of $6.90, with a 52-week high of $12.40 and a 52-week low of $3.21.

Can Indians buy Monte Rosa Therapeutics shares?

Yes, Indians can invest in the Monte Rosa Therapeutics (GLUE) from India.

With INDmoney, you can buy Monte Rosa Therapeutics at 0 brokerage. The step-by-step process is as follows:

  • Open your zero cost US Stocks account and zero balance IND linked savings a/c (this can be done in less than 3 minutes)
  • Transfer funds to your US Stocks account using your IND linked savings a/c (It takes 24 hours excluding Saturday and Sunday). With INDmoney, you get the best INR USD exchange rates.
  • Once funds are transferred successfully, you can buy Monte Rosa Therapeutics at zero transaction cost.

How can I buy Monte Rosa Therapeutics shares from India?

It is very easy to buy Monte Rosa Therapeutics from India. With INDmoney, you can open a US stocks account in less than 3 minutes. Transfer funds in 24 hours and buy stocks very easily - that too at 0 brokerage. All this is done at 0 account opening & management fee, 0 brokerages, and at the same time you get the best rupee-US dollar exchange rate.

Can Fractional shares of Monte Rosa Therapeutics be purchased?

Yes, you can buy fractional shares of Monte Rosa Therapeutics with INDmoney app.

What are the documents required to start investing in Monte Rosa Therapeutics stocks?

To start investing in Monte Rosa Therapeutics, You will need the following documents:

  • Proof of Identification (PAN, Aadhaar etc)
  • Proof of address (Aadhaar, Voter ID etc)

These documents are required as per RBI's guidelines to create your IND linked savings a/c so that you can execute for global fund transfer. The entire process is paperless and can be completed seamlessly.

What are today’s High and Low prices of Monte Rosa Therapeutics

Today’s highest price of Monte Rosa Therapeutics (GLUE) is $7.22.

Today’s lowest price of Monte Rosa Therapeutics (GLUE) is $6.90.

What is today's market capitalisation of Monte Rosa Therapeutics

Today's market capitalisation of Monte Rosa Therapeutics GLUE is 433.1M

What is the 52 Week High and Low Range of Monte Rosa Therapeutics

  • 52 Week High

    $12.40

  • 52 Week Low

    $3.21

What are the historical returns of Monte Rosa Therapeutics?

  • 1 Month Returns

    -18.02%

  • 3 Months Returns

    108.58%

  • 1 Year Returns

    22.4%

  • 5 Years Returns

    -63.53%

Who is the Chief Executive Officer (CEO) of Monte Rosa Therapeutics

Dr. Markus Warmuth M.D. is the current Chief Executive Officer (CEO) of Monte Rosa Therapeutics.